Furthermore, micro-PET examination showed that 89Zr-DFO-J591 was capable to detect PSMA-positive xenografts (i.e., LNCaP) with tumor-to-background > 20 between 48–144 h post-injection. The gene discussed is FOLH1; the disease is neoplasm.